REGistry of Long-term AnTithrombotic TherApy-1
NCT04347200
Angina Pectoris, Arterial Occlusive Diseases
Moscow, Russia
View Trial DetailsNCT Number: NCT07193693
The updated guidelines from the European Society of Cardiology (ESC) for chronic coronary syndrome (CCS) have upgraded the use of IVUS and OCT to a class IA recommendation for complex PCI, based on evidence showing a reduction in serious clinical events, including mortality, compared to conventional angiography alone. Despite this, IVUS and OCT are underutilized in daily practice due to factors such as time, cost, and limited technology availability. Investigating the reasons behind this underuse is necessary, especially now that these technologies are more accessible and cost-effective. Additionally, OCT could be particularly helpful in specific cases such as coronary bifurcations and severe calcifications, warranting further evaluation of its use in these settings.
The objective of the study OCT2ACT is to investigate:
* The main reasons/barriers limiting the use of intracoronary imaging in complex PCI cases where it is indicated as suggested by guidelines; * The main reasons behind the selection of IVUS or OCT in such patients; * In cases where OCT is used, how this technology can influence the procedural planning and optimization in complex clinical settings.
The participating centers will include three cohorts of patients:
1. Cohort intracoronary imaging NO: patients who meet the inclusion/exclusion criteria, but did not undergo intracoronary imaging (IVUS or OCT) due to operator's decision.
The aim is to describe the main reasons/barriers for not using imaging. 2. Cohort intracoronary imaging YES according to guidelines recommendation: patients who meet the inclusion/exclusion criteria and underwent intracoronary imaging as recommended by guidelines.
The aim is to understand the main reasons for the decision to use IVUS or OCT and the clinical benefits perceived by the operator. 3. Cohort intracoronary imaging YES outside guidelines recommendation: patients who meet the inclusion/exclusion criteria and underwent intracoronary imaging (IVUS or OCT) outside.
Interested in participating?
Request Info18 year and older
All sexes
Observational
ASST Papa Giovanni XXIII, Bergamo, Italy
The last update of European Society of Cardiology (ESC) chronic coronary syndrome (CCS) guidelines upgraded the use of intravascular ultrasound (IVUS) imaging and optical coherence tomography (OCT) to class IA in the setting of complex percutaneous coronary intervention (PCI) (in particular left main, true bifurcations, and long lesions).
This strong level of recommendation is based on the recent evidence that intracoronary imaging reduces the incidence of hard clinical endpoints, including mortality, as compared to conventional angiography alone.
Yet, there is compelling evidence documenting the under-utilization of IVUS and OCT in daily practice. Many potential reasons, including time, costs, limited availability of technology, expertise of the operators have been suggested. However, no specific study investigated the reasons behind this malpractice. In particular, these reasons should be investigated now that intracoronary imaging has been upgraded to class I recommendation and that many technologies are available significantly reducing the economic burden. In addition, there are some particular anatomic subsets where OCT could be particularly helpful (bifurcations, severe calcification, acute coronary syndrome patients) and it could be interesting to assess the penetration of this technology in this subset of patients. Finally, these devices can be used also in anatomical subsets (diagnosis and procedural guidance) outside from Guidelines recommendations and it is important to assess their safety and clinical advantage in this setting.
Objective
The OCT2ACT study aims to investigate:
The OCT2ACT is an observational, prospective, multicenter, investigator-driven study.
Participating centers will include three different cohorts of patients:
After Ethic Committee approval and site initiation visit, each participating center will recruit consecutive patients for a time window of 3 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Patients undergoing clinically indicated PCI and having at least one of the following criteria (suggestive for complex PCI) without receiving intracoronary imaging:
Patients undergoing clinically indicated PCI with the guidance of intracoronary imaging (OCT or IVUS) and having at least one of the following criteria (suggestive for complex PCI) receiving imaging:
Time frame: From the enrollment to the end of the procedure
As suggested in the consensus document by Cabana et al, the main reasons/barriers will be classified according to the following groups:
Attitudes (lack of agreement and inertia of previous practice):
Knowledge (lack of awareness and familiarity):
Behavior (external barriers):
Time frame: From enrollment to the end of the procedure
The operator has to define the reason behind the choice of the imaging modality with particular regard to the anticipated benefit related to such choice.
Time frame: from enrollment to the end of the procedure
The operator has to define the reason behind the choice of the imaging modality with particular regard to the anticipated benefit related to such choice in a setting that is outside guidelines recommendations
Time frame: from September to December 2025
Percentage of PCI matching inclusion/exclusion criteria
Time frame: from September to December 2025
Percentage of PCI where intracoronary imaging is used as compared to overall volume of PCI
Time frame: from September to December 2025
Percentage of PCI where intracoronary imaging is used as compared to overall volume of PCI matching inclusion/exclusion criteria
Time frame: from September to December 2025
Association between baseline and procedural characteristics and missing use of intracoronary imaging
Time frame: from enrollment to the end of the procedure
Procedural time. The safety endpoints will be recorded in both the cohorts intracoronary imaging YES and compared to investigate differences.
Time frame: from enrollment to the end of the procedure
Contrast media amount. The safety endpoints will be recorded in both the cohorts intracoronary imaging YES and compared to investigate differences.
Time frame: from enrollment to the end of the procedure
Procedural complications related to OCT or IVUS use. The safety endpoints will be recorded in both the cohorts intracoronary imaging YES and compared to investigate differences.
Time frame: from September to December 2025
Association between baseline and procedural characteristics and IVUS/OCT preference
Time frame: from September to December 2025
Description of timing and modality of the intracoronary imaging
Time frame: from September to December 2025
Description of the operator's perceived advantages by intracoronary imaging use
Time frame: from September to December 2025
Description of OCT penetration over IVUS in bifurcations, LM and stent failure
Contact information is provided by the study sponsor or research team.
Consorzio Futuro in Ricerca
Other
Assessment of Barriers Limiting Optical Coherence Tomography Penetration in Actual Clinical Practice & Training (OCT2ACT) Study
Acronym: OCT2ACT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04347200
Angina Pectoris, Arterial Occlusive Diseases
Moscow, Russia
View Trial DetailsNCT06701032
Angina Pectoris, Arterial Occlusive Diseases
Lévis, Quebec, Canada
View Trial DetailsNCT07130045
Angina Pectoris, Arterial Occlusive Diseases
Kuala Lumpur, Lembah Pantai, Malaysia
View Trial DetailsNCT07511231
Angina Pectoris, Arterial Occlusive Diseases
Beijing, China
View Trial Details